Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
101.73
+2.13 (2.14%)
Oct 12, 2026, 2:29 PM EDT - Market open
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of $176.03 billion as of October 12, 2026. It is the 113th most valuable company in the world and the 69th biggest in the United States. Its market cap has decreased by 23.71% in one year.
Market Cap
176.03B
Enterprise Value
203.15B
1-Year Change
-23.71%
Global Rank
Country Rank
#69 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Abbott Laboratories's market cap has increased from $72.66B to $176.03B, an increase of 142.26%. That is a compound annual growth rate of 3.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 176.03B | -19.20% |
| Dec 31, 2025 | 217.86B | 11.05% |
| Dec 31, 2024 | 196.18B | 2.67% |
| Dec 29, 2023 | 191.09B | -0.18% |
| Dec 30, 2022 | 191.43B | -23.08% |
| Dec 31, 2021 | 248.87B | 28.25% |
| Dec 31, 2020 | 194.06B | 26.33% |
| Dec 31, 2019 | 153.61B | 20.92% |
| Dec 31, 2018 | 127.04B | 27.88% |
| Dec 29, 2017 | 99.34B | 75.66% |
| Dec 30, 2016 | 56.55B | -15.59% |
| Dec 31, 2015 | 66.99B | -1.18% |
| Dec 31, 2014 | 67.79B | 14.39% |
| Dec 31, 2013 | 59.27B | -42.76% |
| Dec 31, 2012 | 103.53B | 18.20% |
| Dec 30, 2011 | 87.59B | 18.28% |
| Dec 31, 2010 | 74.06B | -11.31% |
| Dec 31, 2009 | 83.51B | 0.85% |
| Dec 31, 2008 | 82.81B | -4.56% |
| Dec 31, 2007 | 86.77B | 16.06% |
| Dec 29, 2006 | 74.76B | 22.23% |
| Dec 30, 2005 | 61.16B | -15.81% |
| Dec 31, 2004 | 72.65B | -0.27% |
| Dec 31, 2003 | 72.85B | 16.56% |
| Dec 31, 2002 | 62.50B | -27.79% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medtronic | 113.18B |
| Stryker | 106.38B |
| Boston Scientific | 61.93B |
| Edwards Lifesciences | 49.12B |
| DexCom | 31.74B |
| GE HealthCare Technologies | 29.69B |
| Koninklijke Philips | 23.84B |
| STERIS | 20.90B |